New Blood Test Accurately Predicts Breast Cancer Recurrence Years in Advance

The ultra-sensitive test detects circulating tumor DNA, allowing for earlier intervention and improved survival rates.

The test identifies cancer DNA in the blood before it shows up on scans, found to be 100% accurate in trials.
Researchers from the Institute of Cancer Research conducted the study on 78 patients with early breast cancer.
The blood test detected cancer recurrence an average of 15 months before symptoms appeared.
Early detection through this test could lead to timely treatments, reducing the risk of the cancer becoming incurable.
Experts call the development a breakthrough, though it is still in early stages and not yet widely available.